Diazabicyclo-octane derivatives as 5-HT receptor ligands
申请人:Merck Sharp & Dohme Ltd.
公开号:US06150391A1
公开(公告)日:2000-11-21
Compounds having formula I, or pharmaceutically acceptable salts or prodrugs thereof: ##STR1## are selective agonists of the 5-HT.sub.1D.alpha. receptor and are useful in the treatment of migraine and associated conditions.